We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SCPH market cap is 240.64M. The company's latest EPS is USD -1.0956 and P/E is -4.39.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.64M | 3.8M | 6.1M | 6.1M | 8.05M |
| Operating Income | -13.75M | -14.84M | -15.26M | -15.86M | -14.43M |
| Net Income | -14.15M | -15.63M | -13.81M | -14.11M | -17.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 13.59M |
| Operating Income | -32.91M | -29.93M | -25.82M | -36.16M | -55.4M |
| Net Income | -33M | -32.21M | -28.03M | -36.84M | -54.81M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 114.17M | 106.1M | 94.48M | 78.45M | 65.46M |
| Total Liabilities | 50.74M | 56.96M | 57.26M | 53.89M | 56.21M |
| Total Equity | 63.43M | 49.15M | 37.22M | 24.57M | 9.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 77.28M | 109.05M | 79.04M | 124.2M | 94.48M |
| Total Liabilities | 25.92M | 26.88M | 22.57M | 51.76M | 57.26M |
| Total Equity | 51.37M | 82.17M | 56.47M | 72.43M | 37.22M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.64M | -44.09M | -59.24M | -17.7M | -37.93M |
| Investing | 16.43M | -6.5M | 19.97M | 29.32M | 29.32M |
| Financing | 14.32M | 14.38M | 14.85M | 15k | 298k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.44M | -27.69M | -27.15M | -34.58M | -59.24M |
| Investing | N/A | -33.46M | 32.13M | -45.86M | 19.97M |
| Financing | 13.59M | 60.35M | -2.53M | 77.23M | 14.85M |
| Market Cap | 240.64M |
| Price to Earnings Ratio | -4.39 |
| Price to Sales Ratio | 17.7 |
| Price to Cash Ratio | 5.14 |
| Price to Book Ratio | 6.47 |
| Dividend Yield | - |
| Shares Outstanding | 50.03M |
| Average Volume (1 week) | 357.85k |
| Average Volume (1 Month) | 271.68k |
| 52 Week Change | -31.29% |
| 52 Week High | 7.285 |
| 52 Week Low | 3.24 |
| Spread (Intraday) | 2.97 (38.67%) |
| Company Name | scPharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.scpharmaceuticals.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
